Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

A Guide to Following Up on Your Webinar Leads

XTALKS VITALS PRODUCTION TIPS BLOG

Guide to Following Up on Webinar Leads

In this guide, we are happy to share with you some of the unique insights and tips on how to best to conduct your own follow-up.

Share this!

November 16, 2016 | by Dian Razak


Getting The Best ROI From Your Leads

A Guide to Following Up on Your Webinar Leads

Webinars are a great way to generate leads and build awareness around a company’s services and brands. However, for many companies, the processes and best practices for following up with prospects post-webinar are still being formalized, or worse still, are not being put in place at all. This means lost opportunities and an unrealized ROI.


Every year, Xtalks produces hundreds of webinars and tens of thousands of practitioners access the webinar content hosted on our site. In this guide, we are happy to share with you some of the unique insights and tips on how to best to conduct your own follow-up.
 

In this guide, we cover:

  1. Why webinar leads are different and golden
  2. Key timing on when you should call your prospects
  3. Using statistics in your webinar report to your advantage
  4. How Xtalks Appointment Setting can help in positioning, probing and prospecting.

Through our Xtalks Appointment Setting (XAS) services, we have assisted our clients in their post-webinar follow up with registrants. For those who don’t necessarily have the internal resources to conduct follow-up efficiently, feel free to contact us at xas@xtalks.com to see if we can help.
 d doc icon

Download the
guide here
 

Keywords: Host a Webinar

MORE NEWS
Exclusion Criteria for Clinical Trials Poses Major Barrier to Patient Enrollment

August 17, 2017 - UT Southwestern researchers say that clinical investigators continue to increase the number of exclusion criteria, preventing more patients from participating in clinical trials.

Featured In: Clinical Trials News


Targeting Cellular Nitrogen Metabolism Could Offer a New Treatment for Pancreatic Cancer

August 17, 2017 - An enzyme involved in regulating the amount of nitrogen in the cell could be a new drug target for pancreatic cancer, according to researchers from Boston Children's Hospital and the Broad Institute of MIT and Harvard.

Featured In: Life Science News


Regeneron’s Drug for Respiratory Syncytial Virus Fails in Phase III Clinical Trial

August 16, 2017 - Biotechnology company Regeneron has announced it will not continue development of its antibody drug, suptavumab, after a failure in a Phase III clinical trial.

Featured In: Clinical Trials News


 
  
THE XTALKS VITALS WEBINAR PRODUCTION TIPS BLOG

6 Tips to Overcome Nervousness When Speaking in a Webinar

REGISTER FOR THESE WEBINARS

Data Integrity and the Manufacturing Control Strategy for Life Sciences Manufacturers


Biosimilar Development: Lessons Learned from Early Clinical Studies


Understanding Medical Device Regulatory Pathways in China and Japan


Outsourcing Pharmacovigilance: Pros and Cons and Lessons Learned


Copyright © 2016-2017 Honeycomb Worldwide Inc.